Clinical Performance of Glass-hybrid in the Treatment of Class III Restorations (Class-III)
Class III Dental Caries
About this trial
This is an interventional treatment trial for Class III Dental Caries focused on measuring Glass hybrid restorative, Class III, Anterior restoration, FDI criteria
Eligibility Criteria
Inclusion Criteria: The participant must be at least 18 years of age or older The participant has at least two class III lesions and the lesions are in symmetrical teeth located in the right and left arch The lesion covers at most 2/3 and at least 1/3 of the dentin Participant voluntarily signing the informed consent form The participant does not have a physical disability that may prevent them from coming to the control. Absence of a periapical pathology in the involved tooth Exclusion Criteria: Having systemic disorders that may prevent the participant from regularly attending treatment and control appointments. Having severe periodontal problems in the tooth planned to be treated Absence of the opposite of the tooth and not participating in chewing Lesions which is limited with the enamel tissue Teeth with lesions that are too large to be restored Patients with anterior malocclusion Patients with parafunctional habits. Mentally disabled patients.
Sites / Locations
- Hacettepe University School of DentistryRecruiting
- Hacettepe UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Equia forte HT (glass-hybrid) group
"G-Aenial anterior"
This study planned to investigate the clinical performance of Equia Forte HT (permanent glass hybrid restorative) in the treatment of anterior class III restorations. This arm of the study is the group whose effectiveness was investigated. The results will be evaluated by comparing with a traditional anterior resin composite in terms of functional, biological and aesthetic properties.
This group will serve as a "control". Equia forte HT (glass-hybrid) restorations will compare with the "G-Aenial anterior" anterior resin composite restorations.